|                                                              |
|--------------------------------------------------------------|
|                                                              |  |  |  |  |
| Delaware                                                     |   | 77-0513190 |
| State or other jurisdiction of incorporation or organization |   | I.R.S. Employer Identification No. |
|                                                         |   |   |
| 2 Tower Place, Suite 2000                                    | South San Francisco, | CA |   | 94080 |
| Address of principal executive offices                       |   | Zip Code |

|                                          |
|------------------------------------------|
|                                          |  |  |
| Title of each class                      | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.001 par value per share | FLDM | The Nasdaq Global Select Market |

|                            |
|----------------------------|
|                            |  |  |  |  |  |  |  |
| Large accelerated filer    |   | ☒ |   |   | Accelerated filer |   | ☐ |
| Non-accelerated filer |   | ☐ |   |   | Smaller reporting company |   | ☐ |
|                       |   |   |   |   | Emerging growth company |   | ☐ |

----

----

|          |
|----------|
|          |  |  |
|     |   | Page |
| PART III |   |   |
|     |   |   |
|     | Item 10. Directors, Executive Officers and Corporate Governance | 1 |
|     |   |   |
|     | Item 11. Executive Compensation | 10 |
|     |   |   |
|     | Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 36 |
|     |   |   |
|     | Item 13. Certain Relationships and Related Transactions, and Director Independence | 39 |
|     |   |   |
|     | Item 14. Principal Accounting Fees and Services | 40 |
|     |   |   |
| PART IV  |   |   |
|     |   |   |
|     | Item 15. Exhibits, Financial Statement Schedules | 41 |
|     |   |   |
|     | Signatures | 42 |
|     |   |   |
|     |   |   |
|     |   |   |
|     |   |   |
|     |   |   |

----

|                                |
|--------------------------------|
|                                |  |  |  |  |  |  |  |  |  |
| Name                           |   | Class |   | Age |   | Position |   | Director Since |
| Nicolas M. Barthelemy(1)(2)    |   | I |   | 54 |   | Director |   | 2017 |
| Bill W. Colston(3)             |   | I |   | 52 |   | Director |   | 2019 |
| Patrick S. Jones(3)            |   | I |   | 75 |   | Director |   | 2011 |
| Gerhard F. Burbach(2)(3)       |   | II |   | 58 |   | Director |   | 2013 |
| Carlos Paya(1)(2)              |   | II |   | 61 |   | Director |   | 2017 |
| Laura M. Clague(3)             |   | III |   | 61 |   | Director |   | 2018 |
| Samuel D. Colella(1)           |   | III |   | 80 |   | Chairman |   | 2000 |
| Stephen Christopher Linthwaite |   | III |   | 48 |   | President, Chief Executive Officer, and Director |   | 2016 |

|     |                                                             |
|-----|-------------------------------------------------------------|
| (1) | Member of our Nominating and Corporate Governance Committee |
|     |                                      |
|-----|--------------------------------------|
| (2) | Member of our Compensation Committee |
|     |                               |
|-----|-------------------------------|
| (3) | Member of our Audit Committee |

----

----

----

|                                |
|--------------------------------|
|                                |  |  |  |  |
| Name                           |   | Age |   | Position |
| Stephen Christopher Linthwaite |   | 48 |   | President, CEO, and Director |
| Vikram Jog                     |   | 63 |   | Chief Financial Officer |
| Bradley Kreger                 |   | 45 |   | Senior Vice President, Global Operations |
| Colin McCracken                |   | 47 |   | Chief Commercial Officer |

----

|                       |
|-----------------------|
|                       |  |  |  |  |  |  |
|                  |   | Audit |   | Compensation |   | Nominating and  Corporate Governance |
| Nicolas M. Barthelemy |   | X(1) |   | C(2) |   | X(1) |
| Gerhard F. Burbach    |   | X |   | X(2) |   |   |
| Laura M. Clague       |   | X(3) |   |   |   |   |
| Samuel D. Colella     |   |   |   | X(4) |   | X(5) |
| Bill W. Colston       |   | X |   |   |   |   |
| Patrick S. Jones      |   | C(3) |   |   |   |   |
| Carlos Paya           |   |   |   | X(4) |   | C(5) |
| Meetings in 2019      |   | 6 |   | 5 |   | 5 |

----

|     |                                                                                                                                    |
|-----|------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Mr. Barthelemy stepped down from our Audit Committee and joined our Nominating and Corporate Governance Committee in October 2019. |
|     |                                                              |
|-----|--------------------------------------------------------------|
| (2) | Mr. Barthelemy was appointed to serve as chair in June 2019. |
|     |                                                                                  |
|-----|----------------------------------------------------------------------------------|
| (3) | Board-designated “audit committee financial expert” under SEC rules. |
|     |                                                                                  |
|-----|----------------------------------------------------------------------------------|
| (4) | Mr. Colella left and Dr. Paya joined our Compensation Committee in October 2019. |
|     |                                                                          |
|-----|--------------------------------------------------------------------------|
| (5) | Dr. Paya was appointed to replace Mr. Colella as chair in February 2019. |
|         |                                                                        |
|---------|------------------------------------------------------------------------|
| • | oversee the work of our independent registered public accounting firm; |
|         |                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------|
| • | approve the hiring, discharge, and compensation of our independent registered public accounting firm; |
|         |                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------|
| • | approve engagements of our independent registered public accounting firm to render any audit or permissible non-audit services; |
|         |                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------|
| • | evaluate the qualifications, independence, and performance of our independent registered public accounting firm; |
|         |                                                                                                                                                                                                                   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | discuss and, as appropriate, review with management and our independent registered public accounting firm our annual and quarterly financial statements and our major critical accounting policies and practices; |
|         |                                                                    |
|---------|--------------------------------------------------------------------|
| • | review management’s assessment of our internal controls; and |
|         |                                                                                        |
|---------|----------------------------------------------------------------------------------------|
| • | review the adequacy and effectiveness of our internal control policies and procedures. |
|         |                                                                               |
|---------|-------------------------------------------------------------------------------|
| • | review the compensation and benefits of our CEO and other executive officers; |
|         |                                                                                    |
|---------|------------------------------------------------------------------------------------|
| • | review our corporate goals and objectives relevant to the compensation of our CEO; |
|         |                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------|
| • | assist our Board in providing oversight of the Company’s overall compensation plans and benefits program; and |
|         |                                        |
|---------|----------------------------------------|
| • | administer our equity incentive plans. |
|         |                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------|
| • | evaluate and make recommendations regarding the composition, organization, and governance of the Board and its committees; |
|         |                                                                                                                      |
|---------|----------------------------------------------------------------------------------------------------------------------|
| • | evaluate the performance of members of the Board and make recommendations regarding committee and chair assignments; |
|         |                                                                                                                |
|---------|----------------------------------------------------------------------------------------------------------------|
| • | recommend desired qualifications for Board membership and conduct searches for potential members of the Board; |
|         |                                                                             |
|---------|-----------------------------------------------------------------------------|
| • | review and recommend Board compensation programs for outside directors; and |
|         |                                                                                      |
|---------|--------------------------------------------------------------------------------------|
| • | develop and make recommendations with regard to our corporate governance guidelines. |

----

----

|         |                                                                                                         |
|---------|---------------------------------------------------------------------------------------------------------|
| • | the current size and composition of our Board and the needs of the Board and its respective committees; |
|         |                                                                                                                                                                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | factors such as character, integrity, judgment, diversity of background (including gender, race, and ethnicity) and experience, independence, area of expertise, corporate experience, length of service, potential conflicts of interest, other commitments, and the like; and |
|         |                                                                                                |
|---------|------------------------------------------------------------------------------------------------|
| • | other factors that our Nominating and Corporate Governance Committee may consider appropriate. |
|         |                                                             |
|---------|-------------------------------------------------------------|
| • | the highest personal and professional ethics and integrity; |
|         |                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------|
| • | proven achievement and competence in the nominee’s field and the ability to exercise sound business judgment; |
|         |                                                               |
|---------|---------------------------------------------------------------|
| • | skills that are complementary to those of the existing Board; |
|         |                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------|
| • | the ability to assist and support management and make significant contributions to the Company’s success; and |
|         |                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | an understanding of the fiduciary responsibilities required of a member of the Board and the commitment of time and energy necessary to diligently carry out those responsibilities. |

----

|         |                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------|
| • | provide transparency and visibility into our strategy, our financial and operational performance, and our governance practices; |
|         |                                                                                                   |
|---------|---------------------------------------------------------------------------------------------------|
| • | determine which issues are important to our stockholders and share our views on those issues; and |
|         |                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------|
| • | discuss and seek feedback on our business, executive compensation, and corporate governance policies and practices. |
|         |                                                             |
|---------|-------------------------------------------------------------|
| • | an enterprise-level environment, health, and safety policy, |
|         |                                                                                                                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | a statement of commitment to doing business responsibly by aligning our strategies and global operations with the United Nations Global Compact principles on human rights, labor laws, environmental protection, and corruption in business, |
|         |                                                             |
|---------|-------------------------------------------------------------|
| • | a supply chain transparency and anti-slavery statement, and |
|         |                                                                                                                                                                                                          |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | a business partner code of conduct formally defining our expectations for our distributors, suppliers, vendors, contractors, agents, and all other third parties who provide products or services to us. |

----

|                                |
|--------------------------------|
|                                |  |
| Stephen Christopher Linthwaite | President and CEO |
| Vikram Jog                     | Chief Financial Officer |
| Colin McCracken                | Chief Commercial Officer |
| Bradley Kreger                 | Senior Vice President, Global Operations |
| Nicholas Khadder(1)            | Senior Vice President, General Counsel, and Secretary |

|     |                                                                                                                                                                                       |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | As previously disclosed in the Original 10-K, Mr. Khadder resigned from the Company effective March 13, 2020. Mr. Khadder subsequently rejoined the Company effective April 27, 2020. |
|         |                                                                                                                                                     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Continued revenue growth: Annual revenue of $117.2 million from $113.0 million in 2018, with mass cytometry revenue growth of 23%, compared to 2018 |
|         |                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------|
| • | Launch of over 10 new products for our mass cytometry business, as well as new microfluidics content to drive penetration of new key accounts |
|         |                                           |
|---------|-------------------------------------------|
| • | Strengthened balance sheet and liquidity: |
|         |                                                                                                                                          |
|---------|------------------------------------------------------------------------------------------------------------------------------------------|
| ◦ | March 2019 retirement of the Company’s 2018 2.75% convertible notes due 2034 with an aggregate principal value of $150 million |
|         |                                                                                                                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ◦ | November 2019 private placement of $55.0 million in aggregate principal amount of 5.25% convertible notes due 2024 and concurrent retirement of $50.2 million in aggregate principal amount of the Company’s 2014 2.75% convertible notes due 2034 |
|         |                                                                                 |
|---------|---------------------------------------------------------------------------------|
| ◦ | Maintained a $15 million revolving credit facility with Silicon Valley Bank |
|         |                                                                                      |
|---------|--------------------------------------------------------------------------------------|
| – | In April 2020, the maturity date of such credit facility was extended to August 2022 |
|         |                                                                                                                                                                                                                |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Granted performance-based restricted stock unit awards (“PSUs”) contingent upon total stockholder return over a three-year performance period relative to the companies in the Russell 3000 Index. |
|         |                                                                                                                                                                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Increased the weighting of PSUs to 51% of the annual equity grants—sometimes referred to as long-term incentive compensation (“LTI”)—with the remaining 49% granted in time-based restricted stock units (“RSUs”). |
|         |                                                                                                                                                                                              |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ◦ | For 2020, increased the portion of LTI granted in PSUs from 51% to 55% to further demonstrate the long-term alignment of our executives’ interests with those of our stockholders. |

----

|         |                                                                                                                                                                                                                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Established the 2019 annual executive cash incentive program pursuant to our Executive Bonus Plan (the “2019 Cash Incentive Program”), which measured annual performance based on predefined financial goals with adjustments based on each executive’s strategic goals and contributions. |
|         |                                                                                                                                                                            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Approved payouts under the 2019 Cash Incentive Program of between 18.7% and 25.5% of target, reflecting the Compensation Committee’s rigorous goal setting approach. |
|         |                                                                                            |
|---------|--------------------------------------------------------------------------------------------|
| • | Held all NEO base salaries flat from 2018 levels: no increases were made for 2019 or 2020. |

|                                                        |
|--------------------------------------------------------|
|                                                        |  |  |  |  |  |  |  |  |
| Effect of Company Performance on CEO Realizable Pay(1) |
| Year                                                   |   | TSR  for the Year |   | Salary increase following year end |   | Performance Cash Incentive Awarded, % of Target, Following Year End |   | Realizable Pay as a % of Target Pay measured at December 31, 2019 |
| 2019                                                   |   | -59.6% |   | No increase |   | 18.7% |   | 42.7% |
| 2018                                                   |   | 46.3% |   | No increase |   | 117.0% |   | 63.9% |
| 2017                                                   |   | -19.1% |   | 4% |   | 105.2% |   | 60.9% |

|     |                                                                                                                                                                                        |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | For a discussion of what constitutes “realizable pay” for this purpose, see the explanatory notes to the “CEO Target vs. Realizable Compensation” chart below. |

----

|                            |
|----------------------------|
|                            |  |  |  |  |  |  |
| Compensation Component     |   | Our Prior Practice |   | Investor Feedback |   | What We Did in Response to Investor Feedback |
| Type of Equity Awards      |   | Our equity awards granted to our executive officers were predominantly time-based. |   | Equity awards should include a meaningful amount of performance-based awards in addition to time-based awards. |   | We increased the portion of long-term compensation in PSUs to 51% of total LTI for 2019 (from 25% in 2018 and 0% in 2017) and then to 55% of total LTI for 2020. |
| Clawback Policy            |   | We had not adopted a clawback policy prior to 2018. |   | Incentive compensation should be subject to a clawback. |   | In 2018, we adopted a clawback policy that is applicable to our CEO and all officers who report directly to the CEO, including our NEOs. |
| Stock Ownership Guidelines |   | Prior to 2018, we had not adopted stock ownership guidelines. |   | Executive officers and non-employee members of the Board should be subject to stock ownership guidelines. |   | In 2018, we adopted stock ownership guidelines for our CEO, our other senior executive officers, and the non-employee members of the Board. |

|         |                                                                                   |
|---------|-----------------------------------------------------------------------------------|
| • | Maintain an executive compensation program designed to align pay with performance |
|         |                                                                                                   |
|---------|---------------------------------------------------------------------------------------------------|
| • | Balance near- and long-term strategic objectives by providing a mix of cash and equity incentives |
|         |                                                                           |
|---------|---------------------------------------------------------------------------|
| • | Deliver the majority of compensation in the form of at-risk, variable pay |
|         |                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Award performance-based equity grants—more than half of the equity awards granted to our executive officers in 2019 are subject to performance conditions over a 3-year period |
|         |                                                                                                                                        |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|
| • | Benchmark compensation levels against appropriate companies operating in similar industries, of a similar size and business complexity |
|         |                                                                                    |
|---------|------------------------------------------------------------------------------------|
| • | Reference the market median when reviewing compensation for our executive officers |
|         |                                                                              |
|---------|------------------------------------------------------------------------------|
| • | Maintain stock ownership guidelines for our executive officers and directors |
|         |                                                    |
|---------|----------------------------------------------------|
| • | Maintain an incentive compensation clawback policy |
|         |                                                                                                                                        |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|
| • | Prohibit hedging and pledging of our common stock by our directors, officers, and others with access to material nonpublic information |
|         |                                                                                     |
|---------|-------------------------------------------------------------------------------------|
| • | Conduct an annual assessment to identify and mitigate risk in compensation programs |
|         |                                          |
|---------|------------------------------------------|
| • | Hold an annual stockholder advisory vote |
|         |                                                          |
|---------|----------------------------------------------------------|
| • | Welcome and initiate direct engagement with stockholders |
|         |                                                       |
|---------|-------------------------------------------------------|
| • | Align compensation with the interests of stockholders |
|         |                                                                     |
|---------|---------------------------------------------------------------------|
| • | Engage an independent consultant to advise on executive pay matters |
|         |                                                                                                                          |
|---------|--------------------------------------------------------------------------------------------------------------------------|
| • | Maintain an all-independent Compensation Committee that meets in executive session without members of management present |

----

|         |                                                                                 |
|---------|---------------------------------------------------------------------------------|
| • | Allow excessive severance benefits or single trigger change in control payments |
|         |                                                      |
|---------|------------------------------------------------------|
| • | Offer tax gross-ups to any of our executive officers |
|         |                                         |
|---------|-----------------------------------------|
| • | Pay dividends on unvested equity awards |
|         |                                               |
|---------|-----------------------------------------------|
| • | Offer supplemental executive retirement plans |
|         |                                                                  |
|---------|------------------------------------------------------------------|
| • | Guarantee salary increases or bonuses for our executive officers |
|         |                                      |
|---------|--------------------------------------|
| • | Provide uncapped award opportunities |
|         |                                                               |
|---------|---------------------------------------------------------------|
| • | Encourage excessive risk taking in our incentive plan designs |

|                                                                                               |
|-----------------------------------------------------------------------------------------------|
|                                                                                               |  |
| •    Team-oriented approach to establishing compensation levels.    | We believe that it is critical that our executive officers work together as a team to achieve overall corporate goals rather than focusing exclusively on individual departmental objectives. |
| •    Compensation should relate to performance.                     | We believe that executive compensation should be directly linked to corporate as well as individual performance, with an emphasis on performance-based compensation. |
| •    Equity awards help executive officers think like stockholders. | We believe that our executive officers’ total compensation should have a significant equity component because stock-based awards help reinforce the executive officers’ long-term interest in our overall performance and align the interests of our executive officers with the interests of our stockholders. |
| •    Total compensation opportunities should be competitive.        | We believe that our total compensation programs should be competitive so that we can attract, retain, and motivate talented executive officers who will help us to perform better than our competitors. |

----

|         |                                                                                                                                                                                                                                                     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Target pay is defined as the sum of base salary, target cash incentive opportunity, and the grant date face value of LTI granted during the respective year (i.e., Black-Scholes for stock options and the closing price of our common stock on the |

----

|         |                                                                                                                                                                                                                                                                                                                                                                                                                             |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Realizable pay defined as the sum of base salary, actual cash incentive earned, spread value of options granted during the respective year, RSUs granted in the respective year, and PSUs granted in the respective year at current projected payout levels (currently 0% for both the 2018-2020 and 2019-2021 cycles). LTI values calculated using the closing price of our common stock of $3.48 as of December 31, 2019. |
|         |                                                                                     |
|---------|-------------------------------------------------------------------------------------|
| • | 2017 pay excludes grants made in connection with our stock option exchange program. |
|         |                                                                                                    |
|---------|----------------------------------------------------------------------------------------------------|
| • | assist the Board in providing oversight of our compensation policies, plans, and benefit programs; |
|         |                                                                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | assist the Board in discharging its responsibilities relating to oversight of the compensation of our executive officers (including officers reporting under Section 16 of the Exchange Act); |
|         |                                                                                                                                            |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------|
| • | review and approve or make recommendations to the Board with respect to executive officer compensation, plans, policies, and programs; and |
|         |                                                                                |
|---------|--------------------------------------------------------------------------------|
| • | administer our equity compensation plans for executive officers and employees. |
|         |                                             |
|---------|---------------------------------------------|
| • | is made up of solely independent directors; |
|         |                                                                   |
|---------|-------------------------------------------------------------------|
| • | meets in executive session without members of management present; |
|         |                                                                       |
|---------|-----------------------------------------------------------------------|
| • | engages an independent consultant to advise on executive pay matters; |
|         |                                             |
|---------|---------------------------------------------|
| • | reviews its charter on a regular basis; and |
|         |                                                                                                                                                                       |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | regularly reviews the realizable pay of the CEO and other executive officers in light of the Company’s performance to ensure alignment of pay with performance. |
|         |                                                                                                                                         |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------|
| • | assisting us in confirming and updating an appropriate peer group of companies for purposes of benchmarking our levels of compensation; |
|         |                                                                                |
|---------|--------------------------------------------------------------------------------|
| • | gathering and analyzing compensation data from available compensation surveys; |
|         |                                                                                                                                                                                         |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | advising us on policies related to executive officer and director stock ownership and structuring of such policies relative to peer group companies’ publicly disclosed policies; |

----

|         |                                                                                                              |
|---------|--------------------------------------------------------------------------------------------------------------|
| • | conducting a twice yearly review of compliance and regulation updates related to executive compensation; and |
|         |                                                                                              |
|---------|----------------------------------------------------------------------------------------------|
| • | assisting us in assessing the competitiveness of our executive officer compensation program. |

|                    |
|--------------------|
|                    |  |  |
| Alphatec Holdings  | Enzo Biochem | Natera |
| Apollo Endosurgery | GenMark Diagnostics | Pacific Biosciences of California |
| AtriCure           | Harvard Bioscience | Repligen |
| CareDx             | Invitae | SeaSpine Holdings |
| Codexis            | LeMaitre Vascular | SurModics |
| Cutera             | Meridian Bioscience | Tandem Diabetes Care |
| Digirad            | Mesa Laboratories | Veracyte |
| Endologix          | NanoString Technologies |   |

|                               |
|-------------------------------|
|                               |  |  |  |  |  |  |
| Element                       |   | Description |   | Objective |   | Risk Profile |
|                          |   |   |   |   |   |   |
| Base Salary                   |   | Fixed cash compensation |   | Provide competitive, fixed compensation to attract and retain exceptional executive talent |   | Low |
|                          |   |   |   |   |   |   |
| Annual Cash Incentive Program |   | Annual cash compensation with payouts tied to financial results and individual performance |   | Increase alignment with stockholders by providing a direct financial incentive to achieve annual corporate financial goals |   | Moderate to High |
|                          |   |   |   |   |   |   |
| RSUs                          |   | Awards vest 25% on the first anniversary of the grant date and then in equal quarterly installments over the next 3 years |   | Provide alignment with stockholders and promote retention through the 4-year service-vesting requirement |   | Moderate |
|                          |   |   |   |   |   |   |
| PSUs                          |   | Awards vest after 3 years subject to relative TSR performance against the companies in the Russell 3000 Index |   | Provide performance incentives and align executives’ interests with stockholders by rewarding sustained share price performance and promote retention through the service-vesting requirement |   | High |

----

|                                                                       |
|-----------------------------------------------------------------------|
|                                                                       |  |  |  |  |  |  |
| Named Executive Officers                                              |   | 2018  Base Salary |   | 2019  Base Salary |   | 2019 Base Salary Percentage Change |
|                                                                  |   |   |   |   |   |   |
| Stephen Christopher LinthwaitePresident and CEO                       |   | $564,720 |   | $564,720 |   | — |
| Vikram JogChief Financial Officer                                     |   | $362,274 |   | $362,274 |   | — |
| Colin McCrackenChief Commercial Officer                               |   | — |   | $335,000(1) |   | — |
| Bradley KregerSenior Vice President, Global Operations                |   | $325,000 |   | $325,000 |   | — |
| Nicholas KhadderSenior Vice President, General Counsel, and Secretary |   | $347,471 |   | $347,471 |   | — |

|     |                                                                                                                                      |
|-----|--------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Mr. McCracken joined the Company on March 1, 2019. This represents Mr. McCracken’s annualized base salary at the time of hire. |

|                                          |
|------------------------------------------|
|                                          |  |  |  |  |  |  |
| Named Executive Officer                  |   | Annualized Base Salary |   | Target Cash Incentive as a % of 2019 Base Salary |   | Target Cash Incentive Amount |
|                                     |   |   |   |   |   |   |
| Stephen Christopher Linthwaite |   | $564,720 |   | 80.0% |   | $451,776 |
| Vikram Jog                               |   | $362,274 |   | 55.0% |   | $199,251 |
| Colin McCracken(1)                       |   | $335,000 |   | 55.0% |   | $152,928 |
| Bradley Kreger                           |   | $325,000 |   | 50.0% |   | $162,500 |
| Nicholas Khadder                         |   | $347,471 |   | 50.0% |   | $173,735 |

|     |                                                                                                                                                                                                                                              |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Mr. McCracken became eligible to participate in our 2019 Cash Incentive Program on his hire date in March 2019. The target cash incentive amount he was eligible to earn was based on his pro-rated salary from March to December 2019. |

----

|                     |
|---------------------|
|                     |  |  |  |  |  |  |  |  |  |  |  |  |
| Performance Measure |   | Weight |   | Threshold (% of Target) |   | Target ($M) |   | Maximum (% of Target) |   | FY2019 Result ($M) |   | Weighted  Achievement vs. Target |
| Revenue             |   | 50% |   | 90% |   | $128.3 |   | 120% |   | $117.2 |   | 6.8% |
| Cash                |   | 50% |   | 80% |   | $71.6 |   | 136% |   | $60.7 |   | 11.9% |
|                |   |   |   |   |   |   |   |   |   | Total Funding |   | 18.7% |

|                                |
|--------------------------------|
|                                |  |  |  |  |
| Named Executive Officer        |   | Title |   | Individual Performance Goals |
|                           |   |   |   |   |
| Stephen Christopher Linthwaite |   | President and CEO |   | Revenue Creation, Investor Attraction/Retention, Expense Management |
| Vikram Jog                     |   | Chief Financial Officer |   | 3-year Strategic Plan Development, Enterprise Risk Management (ERM), Extended Forecasting Accuracy |
| Colin McCracken                |   | Chief Commercial Officer |   | Commercial Organization Development, Forecast Management, Revenue Development |
| Bradley Kreger                 |   | Senior Vice President, Global Operations |   | Current and Future ISO Compliance, Order & Inventory Management, Inventory Turn Management |
| Nicholas Khadder               |   | Senior Vice President, General Counsel & Secretary |   | Compliance, Patent Application Process Oversight, Strategic Transactions |

----

|                                     |
|-------------------------------------|
|                                     |  |  |  |  |
| Named Executive Officer             |   | Key Achievements |   | Individual  Performance  Modifier |
|                                |   |   |   |   |
| Stephen Christopher Linthwaite |   | •    Achieved operating expense and gross margin targets•    Recruited key talent (Executive and Board of Directors)•    Recruited new sell side analyst coverage and new investors •    Recognized as Top Employer: in December 2019, our Canadian operation cited as one of Greater Toronto’s Top Employers for 2020•    Delivered new product innovation, including 10 new products and top industry award for new product innovation for the 2nd consecutive year |   | 100% |
| Vikram Jog                          |   | •    Deleveraged debt for equity trade exceeded expectations and stimulated significant appreciation in stock value•    Increased communication with investment community and exceeded expectations in increasing credibility and support from investors and auditors |   | 116% |
| Colin McCracken                     |   | •    Exceeded transition objectives with the departure of the prior CCO•    Implemented improved global forecasting process including standardized reporting and sales training |   | 124% |
| Bradley Kreger                      |   | •    Achieved targeted productivity gains in 2019 above expectations despite significant challenges in the factory environment•    Overachieved on the complicated function move of the reagents team from South San Francisco to two separate operations sites while maintaining move-related turnover below objective targets |   | 136% |

|                                          |
|------------------------------------------|
|                                          |  |  |  |  |  |  |
| Named Executive Officer                  |   | Target Cash Incentive Amount |   | Cash Incentive Awarded |   | Cash Incentive Awarded as a % of 2019 Target Cash Incentive |
|                                     |   |   |   |   |   |   |
| Stephen Christopher Linthwaite |   | $451,776 |   | $84,482 |   | 18.7% |
| Vikram Jog                               |   | $199,251 |   | $43,260 |   | 21.7% |
| Bradley Kreger                           |   | $162,500 |   | $41,388 |   | 25.5% |
| Colin McCracken(1)                       |   | $152,928 |   | $35,326 |   | 23.1% |
| Nicholas Khadder                         |   | $173,735 |   | — |   | N.A. |

|     |                                                                                                                                                                                                                                                                                |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Mr. McCracken became eligible to participate in our 2019 executive cash incentive program on his hire date, March 1, 2019. The estimated future payout amount Mr. McCracken was eligible to earn was based on his salary, pro-rated by month, from March to December 2019. |

----

|         |                                                                                                                   |
|---------|-------------------------------------------------------------------------------------------------------------------|
| • | All LTI is subject to the executive officer’s continued service through the applicable vesting date(s). |
|         |                                                                                                                                                       |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | RSUs generally vest 25% on the first anniversary of the grant date and then in equal installments on a quarterly basis over the next three years. |
|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | PSUs have two vesting components that must be met before the performance award vests: (i) a performance-based component and (ii) a time-based component. PSUs become eligible to vest at the end of 3 years subject to the Company’s relative TSR performance against the Russell 3000. The Compensation Committee established threshold, target and maximum relative TSR performance levels and established a payout percentage curve that relates each level of performance to a payout expressed as a percentage of the target PSUs, as illustrated in the table below: |

|                 |
|-----------------|
|                 |  |  |  |
|            | Relative TSR Rank |   | % PSUs Earned(1) |
| Below Threshold | < 25th Percentile |   | 0% |
| Threshold       | 25th Percentile |   | 50% |
| Target          | 50th Percentile |   | 100% |
| Maximum         | 75th Percentile |   | 200% |

|     |                                                                                                                                                                                                                                                            |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | The number of PSUs that become eligible to vest (if any) will be linearly interpolated for relative TSR performance between the 25th and 50th percentile and for relative TSR performance between the 50th percentile and 75th percentile. |

----

|         |                                                                                                                   |
|---------|-------------------------------------------------------------------------------------------------------------------|
| • | the Company’s performance during Mr. Linthwaite’s tenure as CEO through the February 2019 grant date; |
|         |                                                    |
|---------|----------------------------------------------------|
| • | the Board’s desire to retain his leadership; |
|         |                                                                                            |
|---------|--------------------------------------------------------------------------------------------|
| • | targeted market positioning as compared to an appropriately sized benchmarking peer group; |
|         |                                                                                       |
|---------|---------------------------------------------------------------------------------------|
| • | the fact that Mr. Linthwaite did not receive an increase to base salary for 2019; and |
|         |                                                                                                    |
|---------|----------------------------------------------------------------------------------------------------|
| • | strengthened alignment of Mr. Linthwaite interests with those of the Company’s stockholders. |

|                                |
|--------------------------------|
|                                |  |  |  |  |
|                           |   | 2019 |
| Named Executive Officer        |   | RSUs(1) |   | PSUs |
| Stephen Christopher Linthwaite |   | 110,112 |   | 114,607 |
| Vikram Jog                     |   | 35,787 |   | 37,247 |
| Colin McCracken                |   | 76,455(2) |   | 25,500 |
| Bradley Kreger                 |   | 35,787 |   | 37,247 |
| Nicholas Khadder(3)            |   | 33,034 |   | 34,382 |

|     |                                                                                                                                                                                                              |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | RSUs vest over four years, with 1/4th of the total number of shares subject thereto vesting on February 20, 2020 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|     |                                                                                                                           |
|-----|---------------------------------------------------------------------------------------------------------------------------|
| (2) | Includes 51,955 RSUs received as new hire grants under the 2017 Inducement Plan, 10,391 of which vested on June 10, 2019. |
|     |                                                                                                                                                              |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3) | Mr. Khadder’s resignation from the Company in March 2020 resulted in the cancellation and forfeiture of 24,776 then-unvested RSUs and all of the PSUs. |
|         |                                                                                                                                       |
|---------|---------------------------------------------------------------------------------------------------------------------------------------|
| • | TSR encourages long-term strategic focus on creation of stockholder value beyond executives’ financial and operational targets; |
|         |                                                                                   |
|---------|-----------------------------------------------------------------------------------|
| • | the current PSU design requires Fluidigm to out-perform a broad market index; and |
|         |                                                                                                                         |
|---------|-------------------------------------------------------------------------------------------------------------------------|
| • | the analysis did not support a compelling reason to select an industry-specific comparison group over the Russell 3000. |

----

----

|         |                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------|
| • | the expected time required for an executive officer to find comparable employment following a termination event; |
|         |                                                                                                                                                                                                                           |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | feedback received from potential candidates for executive officer positions at our Company as to the level of severance payments and benefits they would require in order to leave other employment and join our Company; |
|         |                                                                                                                                                                                                                                                    |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | in the context of a change of control, the amount of vesting acceleration that would align the executive officer’s interests more closely with the interests of stockholders when considering a potential change of control transaction; and |
|         |                                                                                                                                                   |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------|
| • | the period of time following a change of control during which management positions are evaluated and subject to a heightened risk of elimination. |

----

----

|                                                       |
|-------------------------------------------------------|
|                                                       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Name and Principal Position                           |   | Year |   | Salary ($) |   | Bonus($)(1) |   | Stock Awards  ($)(2) |   | Option Awards  ($)(2) |   | Non-Equity  Incentive Plan  Compensation  ($)(3) |   | All Other  Compensation  ($) |   | Total  ($) |
| Stephen Christopher Linthwaite                   |   | 2019 |   | 564,720 |   | — |   | 3,024,338 |   | — |   | 84,482 |   | 39,515(4) |   | 3,713,055 |
| President and CEO                                     |   | 2018 |   | 553,860 |   | — |   | 1,186,155 |   | 344,884 |   | 461,794 |   | 38,515 |   | 2,585,213 |
|                                                  |   | 2017 |   | 521,500 |   | — |   | 468,160 |   | 591,695 |   | 400,000 |   | 38,515 |   | 2,019,870 |
| Vikram Jog                                            |   | 2019 |   | 362,274 |   | — |   | 982,911 |   | — |   | 43,260 |   | 3,000(5) |   | 1,391,445 |
| Chief Financial Officer                               |   | 2018 |   | 355,979 |   | 122,122 |   | 341,734 |   | 99,312 |   | 204,390 |   | 2,000 |   | 1,125,539 |
|                                                  |   | 2017 |   | 344,592 |   | — |   | 213,136 |   | 272898 |   | 141,500 |   | 2,000 |   | 974,126 |
| Colin McCracken(6)                               |   | 2019 |   | 246,800(7) |   | — |   | 1,504,474 |   | — |   | 35,326 |   | 125,164(8) |   | 1,911,764 |
| Chief Commercial Officer                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Bradley Kreger(9)                                     |   | 2019 |   | 325,000 |   | — |   | 982,911 |   | — |   | 41,388 |   | 3,000(5) |   | 1,352,299 |
| Senior Vice President, Global Operations              |   | 2018 |   | 243,750 |   | — |   | 295,000 |   | 338,930 |   | 115,517 |   | 2,000 |   | 995,197 |
|                                                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Nicholas Khadder(10)                                  |   | 2019 |   | 347,471 |   | — |   | 907,304 |   | — |   | — |   | 3,000(5) |   | 1,257,775 |
| Senior Vice President, General Counsel, and Secretary |   | 2018 |   | 341,110 |   | 150,472 |   | 341,734 |   | 99,312 |   | 156,831 |   | 2,000 |   | 1,091,461 |
|                                                  | 2017 |   | 326,125 |   | — |   | 194,656 |   | 247,606 |   | 155,500 |   | 1,323 |   | 925,210 |

|     |                                                                                                |
|-----|------------------------------------------------------------------------------------------------|
| (1) | Amounts represent the value of RSUs received pursuant to our retention bonus exchange program. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Amounts represent the aggregate grant date fair value of equity awards granted to the NEO in the year indicated (other than the new options granted in the 2017 option exchange program), calculated in accordance with FASB Topic ASC 718 without regard to estimated forfeitures. The 2019 and 2018 PSUs were valued on the target outcome of performance-based conditions (i.e., based on 100% achievement); the maximum achievable outcome for such PSUs is 200%. See Note 10 of the notes to our audited consolidated financial statements included in our Original 10-K for a discussion of assumptions made in determining the grant date fair value and compensation expense of our equity awards. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3) | The amounts in this column represent total performance-based bonuses earned pursuant to our annual cash incentive program under the Executive Bonus Plan for service rendered during the applicable year. All such amounts were paid subsequent to year end. For a description of our annual cash incentive program, please see the section entitled “Annual Cash Incentive Program” under “Compensation Discussion and Analysis” above. |
|     |                                                                                                                                                                                                                                                                       |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | Consists of Company contributions of $3,000 made to Mr. Linthwaite’s 401(k) defined contribution plan, $27,500 of payments made by the Company for life insurance policy premiums, and $9,015 of payments made by the Company in disability insurance premiums. |
|     |                                                                                                        |
|-----|--------------------------------------------------------------------------------------------------------|
| (5) | Consists of Company contributions made to the applicable NEO’s 401(k) defined contribution plan. |
|     |                                                                          |
|-----|--------------------------------------------------------------------------|
| (6) | Mr. McCracken joined Fluidigm as Chief Commercial Officer in March 2019. |
|     |                                                                                                                                                                                                                                                                                                                                                                 |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (7) | Based on conversion of British Pounds (GBP) to US Dollars (USD) from March 1, 2019 to August 31, 2019 at a rate of 1 GBP to 1.2774 USD, and conversion of Canadian Dollars (CAD) to USD from September 1, 2019 to December 31, 2019 at a rate of 1 CAD to 0.7539 USD, the average exchange rates for the period beginning January 1, 2019 to December 31, 2019. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (8) | Consists of Company contributions of $13,715 made to Mr. McCracken’s UK pension plan from March 1, 2019 to August 31, 2019, $1,900 of payments made by the Company for Canadian comprehensive medical coverage premiums from September 1, 2019 to December 31, 2019, $64,615 of payments made by the Company for relocation expenses, $6,860 of payments made by the Company for car allowance, $31,500 of payments made by the Company for living expenses, and $6,574 of payments made by the Company for education and tuition amounts for Mr. McCracken’s dependent child. |
|     |                                                                                       |
|-----|---------------------------------------------------------------------------------------|
| (9) | Mr. Kreger joined Fluidigm as Senior Vice President, Global Operations in April 2018. |
|      |                                                                                                                                      |
|------|--------------------------------------------------------------------------------------------------------------------------------------|
| (10) | Mr. Khadder’s resignation from the Company in March 2020 resulted in the forfeiture of all of his then-unvested equity awards. |

----

|                                     |
|-------------------------------------|
|                                     |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                |   |   |   | Estimated Future Payouts Under  Non-Equity Incentive Plan Awards ($)(1) |   | Estimated Future Payments Under  Equity Incentive Plan Awards (#) |   | All Other Stock  Awards:  Number  of Shares  of Stock  or Units(#) |   | Grant Date  Fair Value of Stock and  Option  Awards($)(2) |
| Name                                |   | Grant Date |   | Threshold |   | Target |   | Maximum |   | Threshold |   | Target |   | Maximum |   |   |
| Stephen Christopher Linthwaite |   | 02/05/2019(3) |   | 406,598 |   | 451,776 |   | 1,129,440 |   | — |   | — |   | — |   | — |   | — |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | 57,303 |   | 114,607 |   | 229,214 |   | — |   | 1,897,892 |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 110,112(4) |   | 1,126,446 |
| Vikram Jog                          |   | 02/05/2019(3) |   | 179,325 |   | 199,251 |   | 498,126 |   | — |   | — |   | — |   | — |   | — |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | 18,623 |   | 37,247 |   | 74,494 |   | — |   | 616,810 |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 35,787(4) |   | 366,101 |
| Colin McCracken                     |   | 02/05/2019(3)(5) |   | 137,635 |   | 152,928 |   | 382,319 |   | — |   | — |   | — |   | — |   | — |
|                                |   | 03/10/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 41,564(6) |   | 485,883 |
|                                |   | 03/10/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 10,391(6) |   | 121,471 |
|                                |   | 04/30/2019 |   | — |   | — |   | — |   | 12,750 |   | 25,500 |   | 51,000 |   | — |   | 560,490 |
|                                |   | 04/30/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 24,500(4) |   | 336,630 |
| Bradley Kreger                      |   | 02/05/2019(3) |   | 146,250 |   | 162,500 |   | 406,250 |   | — |   | — |   | — |   | — |   | — |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | 18,623 |   | 37,247 |   | 74,494 |   | — |   | 616,810 |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 35,787(4) |   | 366,101 |
| Nicholas Khadder                    |   | 02/05/2019(3) |   | 156,362 |   | 173,735 |   | 434,338 |   | — |   | — |   | — |   | — |   | — |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | 17,191 |   | 34,382 |   | 68,764 |   | — |   | 569,366 |
|                                |   | 02/19/2019 |   | — |   | — |   | — |   | — |   | — |   | — |   | 33,034(4) |   | 337,938 |

|     |                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | The target amounts shown in this column reflect our annual incentive plan awards provided under our 2019 Cash Incentive Program. The maximum amounts in this column reflect the greatest payouts that could be made if pre-established maximum performance levels were met or exceeded. Actual 2019 Cash Incentive Program payouts are reflected in the non-equity incentive plan compensation column of the Summary Compensation Table. |
|     |                                                                                                                                                                                                                                                                                                                                                                 |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | All amounts reported represent the grant date fair value of the equity awards, calculated in accordance with FASB ASC Topic 718 without regard to estimated forfeitures. See Note 10 of the notes to our audited consolidated financial statements included in our Original 10-K for a discussion of assumptions made in determining the grant date fair value. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3) | Corresponds to the date on which our Compensation Committee set the target cash incentive amounts payable to each of our executive officers pursuant to our 2019 Cash Incentive Program. Under our 2019 Cash Incentive Program, the payouts were based on achievement of Company and individual performance goals, as discussed in the section of our Compensation Discussion & Analysis titled “2019 Cash Incentive Program — Cash Incentive Program Structure.” |
|     |                                                                 |
|-----|-----------------------------------------------------------------|
| (4) | Represents awards granted under our 2011 Equity Incentive Plan. |
|     |                                                                                                                                                                     |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5) | Mr. McCracken joined Fluidigm as Chief Commercial Officer on March 1, 2019 and was eligible to participate in the 2019 Cash Incentive Program as of his start date. |
|     |                                                                 |
|-----|-----------------------------------------------------------------|
| (6) | Represents awards granted under our 2017 Inducement Award Plan. |

----

|                              |
|------------------------------|
|                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                         |   | Option Awards |   | Stock Awards |
| Name                         |   | Number of Securities Underlying Unexercised Options (#) Exercisable |   | Number of Securities Underlying Unexercised Options (#) Unexercisable |   | Equity  Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |   | Option Exercise Price ($) |   | Option Expiration Date |   | Number of Shares or Units of Stock that Have Not Vested (#) |   | Market Value of Shares or Units of Stock that Have Not Vested ($)(1) |   | EquityIncentive  Plan Awards: Number of UnearnedShares,  Units or Other Rights That Have Not Vested(#) |   | EquityIncentive Plan Awards: Market orPayout Value of Unearned Shares, Units or Other Rights That Have Not Vested($)(1) |
| Stephen Christopher     |   | 110,833(2)  |   | 29,167 |   | — |   | 4.99 |   | 11/8/2026 |   | 22,167(3)  |   | 77,141 |   | — |   | — |
|    Linthwaite |   | 138,174(4)  |   | 51,326 |   | — |   | 6.16 |   | 2/13/2027 |   | 78,128(5) |   | 271,885 |   | — |   | — |
|                         |   | 46,666(6) |   | 23,334 |   | — |   | 5.13 |   | 9/20/2027 |   | 110,112(7) |   | 383,190 |   | — |   | — |
|                         |   | 41,786(8) |   | 53,714 |   | — |   | 6.33 |   | 3/19/2028 |   | — |   | — |   | 54,500(9) |   | 189,660 |
|                         |   | — |   | — |   | — |   | — |   | — |   | — |   | — |   | 114,607(10) |   | 398,832 |
| Vikram Jog                   |   | 63,728(4)  |   | 23,672 |   | — |   | 6.16 |   | 2/13/2027 |   | 226(11)  |   | 786 |   | — |   | — |
|                         |   | 1,027(6) |   | 514 |   | — |   | 5.13 |   | 9/20/2027 |   | 10,092(3)  |   | 35,120 |   | — |   | — |
|                         |   | 1,382(6) |   | 691 |   | — |   | 5.13 |   | 9/20/2027 |   | 22,510(5)  |   | 78,335 |   | — |   | — |
|                         |   | 2,296(6) |   | 1,148 |   | — |   | 5.13 |   | 9/20/2027 |   | 35,787(7) |   | 124,539 |   | — |   | — |
|                         |   | 4,406(6) |   | 2,203 |   | — |   | 5.13 |   | 9/20/2027 |   | — |   | — |   | 15,700(9) |   | 54,636 |
|                         |   | 5,960(6) |   | 2,981 |   | — |   | 5.13 |   | 9/20/2027 |   | — |   | — |   | 37,247(10) |   | 129,620 |
|                         |   | 644(6) |   | 323 |   | — |   | 5.13 |   | 9/20/2027 |   | — |   | — |   | — |   | — |
|                         |   | 12,033(8) |   | 15,467 |   | — |   | 6.33 |   | 3/19/2028 |   | — |   | — |   | — |   | — |
| Colin McCracken              |   | — |   | — |   | — |   | — |   | — |   | 41,564(12)(13) |   | 144,643 |   | — |   | — |
|                         |   | — |   | — |   | — |   | — |   | — |   | 24,500(13) |   | 85,260 |   | — |   | — |
|                         |   | — |   | — |   | — |   | — |   | — |   | — |   | — |   | 25,500(10) |   | 88,740 |
| Bradley Kreger               |   | 41,673(12)(14) |   | 58,327 |   | — |   | 5.90 |   | 4/30/2028 |   | 31,250(12)(15) |   | 108,750 |   | — |   | — |
|                         |   | — |   | — |   | — |   | — |   | — |   | 35,787(7) |   | 124,539 |   | — |   | — |
|                         |   | — |   | — |   | — |   | — |   | — |   | — |   | — |   | 37,247(10) |   | 129,620 |
| Nicholas Khadder(16)         |   | 9,000(6) |   | 4,500 |   | — |   | 5.13 |   | 9/20/2027 |   | 1,575(17) |   | 5,481 |   | — |   | — |
|                         |   | 37,762(6) |   | 18,881 |   | — |   | 5.13 |   | 9/20/2027 |   | 9,217(3) |   | 32,075 |   | — |   | — |
|                         |   | 12,033(8) |   | 15,467 |   | — |   | 6.33 |   | 3/19/2028 |   | 22,510(5) |   | 78,335 |   | — |   | — |
|                         |   | — |   | — |   | — |   | — |   | — |   | 33,034(7) |   | 114,958 |   | — |   | — |
|                         |   | — |   | — |   | — |   | — |   | — |   | — |   | — |   | 15,700(9) |   | 54,636 |
|                         |   | — |   | — |   | — |   | — |   | — |   | — |   | — |   | 34,382(10) |   | 119,649 |

|     |                                                                                                                                                                                                                      |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Based on the closing price of our common stock of $3.48 per share on December 31, 2019, as reported on the Nasdaq Global Select Market, and the number of RSUs and PSUs that had not vested as of December 31, 2019. |
|     |                                                                                                                                                                                                         |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | The option vests over four years, with 1/4th of the total number of shares subject thereto vesting on October 19, 2017 and 1/48th of such shares vesting monthly thereafter until fully vested. |
|     |                                                                                                                                                                                                              |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3) | The RSUs vest over four years, with 1/12th of the total number of shares subject thereto vesting on May 20, 2017 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|     |                                                                                                                                                                                                       |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | The option vests over four years, with 5/16th of the total number of shares subject thereto vesting on March 1, 2018 and 1/48th of such shares vesting monthly thereafter until fully vested. |
|     |                                                                                                                                                                                                                 |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5) | The RSUs vest over four years, with 1/16th of the total number of shares subject thereto vesting on August 20, 2018 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|     |                                                                                                                                                                                                                      |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6) | The option vests over four years, with 1/12th of the total number of shares subject thereto vesting on February 20, 2018 and 1/12th of such shares vesting every three months thereafter until fully vested. |
|     |                                                                                                                                                                                                                  |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (7) | The RSUs vest over four years, with 1/4th of the total number of shares subject thereto vesting on February 20, 2020 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|     |                                                                                                                                                                                                       |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (8) | The option vests over four years, with 1/4th of the total number of shares subject thereto vesting on March 19, 2019 and 1/48th of such shares vesting monthly thereafter until fully vested. |

----

|     |                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (9) | These PSUs become eligible to vest at the end of three years subject to the Company’s relative TSR performance against the Russell 3000 Index as of the beginning of 2018 during the performance period from January 1, 2018 to December 31, 2020. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. |
|      |                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (10) | These PSUs become eligible to vest at the end of three years subject to the Company’s relative TSR performance against the Russell 3000 Index as of the beginning of 2019 during the performance period from January 1, 2019 to December 31, 2021. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. |
|      |                                                                                                                                                                                                              |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (11) | The RSUs vest over four years, with 1/12th of the total number of shares subject thereto vesting on May 20, 2016 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|      |                                                         |
|------|---------------------------------------------------------|
| (12) | Represents RSUs granted under our 2017 Inducement Plan. |
|      |                                                                                                                                                                                                             |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (13) | The RSUs vest over four years, with 1/4th of the total number of shares subject thereto vesting on May 20, 2020 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|      |                                                                                                                                                                                                      |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (14) | The option vests over four years, with 1/4th of the total number of shares subject thereto vesting on April 2, 2019 and 1/48th of such shares vesting monthly thereafter until fully vested. |
|      |                                                                                                                                                                                                             |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (15) | The RSUs vest over four years, with 1/4th of the total number of shares subject thereto vesting on May 20, 2019 and 1/16th of such shares vesting every three months thereafter until fully vested. |
|      |                                                                                                                                 |
|------|---------------------------------------------------------------------------------------------------------------------------------|
| (16) | Mr. Khadder’s resignation from the Company in March 2020 resulted in the forfeiture of all of his unvested equity awards. |
|      |                                                                                                                                                                                                                 |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (17) | The RSUs vest over four years, with 7/24th of the total number of shares subject thereto vesting on August 20, 2017 and 1/16th of such shares vesting every three months thereafter until fully vested. |

----

|                                |
|--------------------------------|
|                                |  |  |  |  |  |  |  |  |
|                           |   | Option Awards |   | Stock Awards |
| Name                           |   | Number of  Shares  Acquired on  Exercise (#) |   | Value Realized on  Exercise ($) |   | Number of  Shares  Acquired on  Vesting (#) |   | Value Realized on  Vesting ($)(1) |
| Stephen Christopher Linthwaite |   | — |   | — |   | 50,248 |   | 392,688 |
| Vikram Jog                     |   | — |   | — |   | 19,205 |   | 150,683 |
| Colin McCracken                |   | — |   | — |   | 10,391 |   | 133,940 |
| Bradley Kreger                 |   | — |   | — |   | 18,750 |   | 177,813 |
| Nicholas Khadder               |   | — |   | — |   | 19,604 |   | 153,205 |

|     |                                                                                                                                                                            |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Value realized on vesting of stock awards is based on the closing price of our common stock on the vesting date and does not necessarily reflect actual proceeds received. |
|         |                                                                                                                                                                                                                                                                                                                                               |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Continued payments (less applicable withholdings) totaling 75% of the NEO’s annual base salary in effect as of the date of termination in equal installments over a period of nine months (or, in the case of our CEO, 200% of his annual base salary paid in equal installments over a period of 24 months) following his termination. |
|         |                                                                                                                                                                                                                                |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Reimbursement of costs of continued health coverage for the NEO, his or her spouse, and/or his or her dependents, as applicable, for a period of up to 9 months (or, in the case of our CEO, 12 months) following termination. |
|         |                                                                                                                                                                                                 |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Reasonable outplacement services in accordance with any applicable policy of ours that is in effect as of the NEO’s termination (or if no such policy is in effect, as determined by us). |
|         |                                                                                                                                                                                                                                                                                                                                                                        |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | A lump-sum payment (less applicable withholdings) totaling 150% (or, in the case of our CEO, 200%) of the sum of (x) his or her annual base salary (as in effect immediately before termination or immediately before the change of control, whichever is higher) plus (y) the greater of (A) his or her annual target cash incentive (as in effect immediately before |

----

|         |                                                                                                                                                                                                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Reimbursement of costs of continued health coverage for the NEO, his or her spouse, and/or his or her dependents, as applicable, for a period of up to 18 months (or, in the case of our CEO, 24 months) following termination. |
|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | 100% vesting acceleration of his or her then-outstanding and unvested equity awards, provided that, if an equity award is to vest and/or the amount of the award to vest is to be determined based on the achievement of performance criteria, then, unless otherwise provided in the applicable equity award agreement, 100% of such equity award will vest assuming the applicable performance criteria had been achieved at target levels for the relevant performance period(s). |
|         |                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Reasonable outplacement services in accordance with any applicable policy of ours that is in effect as of the NEO’s termination (or if no such policy is in effect, as determined by us), except that such outplacement services will be in no case less than the outplacement services provided under any applicable policy of ours that is in effect immediately prior to the applicable change of control. |

|                                |
|--------------------------------|
|                                |  |  |  |  |  |  |  |  |  |  |
|                           |   | Employment Terminated for  Reason Other than Cause, Death, or Disability More Than 3 Months Prior to, or More Than 12 Months After, a Change of Control |   | Employment Terminated for Reason Other  Than Cause, Death or Disability Within  3 Months Prior to or 12 Months After  a Change of Control(1)  |
| Name                           |   | Severance  Payments ($) |   | Health Care Benefits ($) |   | Equity Acceleration ($)(2) |   | Severance Payments ($) |   | Health Care Benefits ($) |
| Stephen Christopher Linthwaite |   | 1,129,440(3) |   | 28,346(4) |   | 1,320,709 |   | 2,032,992(5) |   | 56,691(6) |
| Vikram Jog                     |   | 271,706(7) |   | 21,259(8) |   | 423,036 |   | 842,286(9) |   | 42,518(10) |
| Colin McCracken                |   | 251,250(7) |   | 2,689(11) |   | 318,643 |   | 778,875(9) |   | 5,378(12) |
| Bradley Kreger                 |   | 243,750(7) |   | 21,259(8) |   | 362,908 |   | 731,250(9) |   | 42,518(10) |
| Nicholas Khadder               |   | 260,603(7) |   | 21,259(8) |   | 405,135 |   | 781,809(9) |   | 42,518(10) |

|     |                                                                                                                                                                                    |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Includes termination of the employee’s employment by the Company or its successor without “cause” and termination by the employee for “good reason.” |
|     |                                                                                                                                                                                                                                                                                                                                  |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | We estimate the value of the acceleration of options and RSUs held by the NEO based on the closing stock price of our common stock of $3.48 per share on December 31, 2019, as reported on the Nasdaq Global Select Market, and the number of unvested in-the-money options and shares held by such NEO as of December 31, 2019. |
|     |                                                                                                         |
|-----|---------------------------------------------------------------------------------------------------------|
| (3) | The amount shown is equal to 200% of Mr. Linthwaite’s annual base salary as of December 31, 2019. |
|     |                                                                                                                                                                                                            |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | The amount shown is equal to the cost of covering Mr. Linthwaite and his eligible dependents under our benefit plans for a period of 12 months, assuming that such coverage is timely elected under COBRA. |

----

|     |                                                                                                                                                                                           |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5) | The amount shown is equal to 200% of the sum of (a) Mr. Linthwaite’s annual base salary as of December 31, 2019, plus (b) his annual target cash incentive as of December 31, 2019. |
|     |                                                                                                                                                                                                            |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6) | The amount shown is equal to the cost of covering Mr. Linthwaite and his eligible dependents under our benefit plans for a period of 24 months, assuming that such coverage is timely elected under COBRA. |
|     |                                                                                                 |
|-----|-------------------------------------------------------------------------------------------------|
| (7) | The amount shown is equal to 75% of the NEO’s annual base salary as of December 31, 2019. |
|     |                                                                                                                                                                                                                               |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (8) | The amount shown is equal to the cost of covering the NEO and his eligible dependents under our benefit plans for a period of nine months, assuming that such coverage is timely elected under COBRA for such U.S.-based NEO. |
|     |                                                                                                                                                                                    |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (9) | The amount shown is equal to 150% of the sum of (a) the NEO’s annual base salary as of December 31, 2019, plus (b) his annual target cash incentive as of December 31, 2019. |
|      |                                                                                                                                                                                                                             |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (10) | The amount shown is equal to the cost of covering the NEO and his eligible dependents under our benefit plans for a period of 18 months, assuming that such coverage is timely elected under COBRA for such U.S.-based NEO. |
|      |                                                                                                                                                                                                                                                                                                                                         |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (11) | The amount shown is equal to the cost of covering Mr. McCracken and his eligible dependents under our Canadian benefit plans for a period of 9 months. Based on conversion of Canadian Dollars (CAD) to USD at a rate of 1 CAD to 0.7539 USD, the average exchange rates for the period beginning January 1, 2019 to December 31, 2019. |
|      |                                                                                                                                                                                                                                                                                                                       |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (12) | The amount shown is equal to the cost of covering Mr. McCracken and his eligible dependents under our Canadian benefit plans for a period of 18 months. Based on conversion of CAD to USD at a rate of 1 CAD to 0.7539 USD, the average exchange rates for the period beginning January 1, 2019 to December 31, 2019. |

----

----

|                                                                                         |
|-----------------------------------------------------------------------------------------|
|                                                                                         |  |  |  |
| Annual cash retainer for each non-employee director                                     | $ | 40,000 |  |
| Annual cash retainer for each Audit Committee Member                                    | $ | 10,000 |  |
| Annual cash retainer for each Compensation Committee member                             | $ | 7,000 |  |
| Annual cash retainer for each Nominating and Corporate Governance Committee member      | $ | 5,000 |  |
| Additional cash retainer for chairmanship of the Board                                  | $ | 40,000 |  |
| Additional cash retainer for chairing the Audit Committee                               | $ | 10,000 |  |
| Additional cash retainer for chairing the Compensation Committee                        | $ | 8,000 |  |
| Additional cash retainer for chairing the Nominating and Corporate Governance Committee | $ | 5,000 |  |

|                |
|----------------|
|                |  |  |  |  |  |  |
|           |   |   |   | Grant Date Value: |
| Type of Award  |   | Description |   | Restricted Stock Units (RSUs) |   | Stock Options |
| Initial Awards |   | Granted to new non-employee directors upon initial election / appointment |   | $55,000 |   | $55,000 |
| Annual Awards  |   | Granted to continuing non-employee directors on the date of each annual meeting of the Company’s stockholders following election / appointment |   | $50,000 |   | $50,000 |

|         |                                                                                                 |
|---------|-------------------------------------------------------------------------------------------------|
| • | Initial Option Awards and Initial RSU Awards vest in equal annual installments over four years. |
|         |                                                                                    |
|---------|------------------------------------------------------------------------------------|
| • | Annual Option Awards vest and become exercisable in 12 equal monthly installments. |
|         |                                                                                                                                                                                                      |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | Annual RSU Awards vest in full on the earlier to occur of (i) the first anniversary of the grant date and (ii) one day prior to the date of the Company’s next annual meeting of stockholders. |

----

----

|                       |
|-----------------------|
|                       |  |  |  |  |  |  |  |  |
|                  |   | Fees Earned or Paid in Cash ($) |   | Stock Awards($)(1) |   | Option Awards($)(1) |   | Total  ($) |
| Nicolas M. Barthelemy |   | 59,750 |   | 53,466 |   | 49,999 |   | 163,215 |
| Gerhard F. Burbach    |   | 61,000 |   | 53,466 |   | 49,999 |   | 164,465 |
| Laura M. Clague       |   | 50,000 |   | 53,466 |   | 49,999 |   | 153,465 |
| Samuel D. Colella     |   | 96,993(2) |   | 53,466 |   | 49,999 |   | 200,458 |
| Bill W. Colston       |   | 22,500 |   | 53,811 |   | 54,998 |   | 131,309 |
| Patrick S. Jones      |   | 60,000 |   | 53,466 |   | 49,999 |   | 163,465 |
| Carlos Paya           |   | 50,494(2) |   | 53,466 |   | 49,999 |   | 153,959 |

|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Amounts represent the aggregate grant date fair value of the option award and RSU awards, as applicable, calculated in accordance with Financial Accounting Standards Board ASC Topic 718, Stock Compensation, as amended, without regard to estimated forfeitures. See Note 9 of the notes to our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 for a discussion of valuation assumptions made in determining the grant date fair value and compensation expense of our stock options and RSU awards. |
|     |                                                              |
|-----|--------------------------------------------------------------|
| (2) | Amount includes RSUs received in lieu of cash fees for 2019. |

|                       |
|-----------------------|
|                       |  |  |  |  |
|                  |   | Aggregate Number of Shares  Underlying Stock Options  Outstanding as of  December 31, 2019 |   | Aggregate Number of Shares  Underlying RSUs  Outstanding as of  December 31, 2019 |
| Nicolas M. Barthelemy |   | 40,396 |   | 8,987 |
| Gerhard F. Burbach    |   | 92,396 |   | 34,202(1) |
| Laura M. Clague       |   | 21,796 |   | 13,987(1) |
| Samuel D. Colella     |   | 26,796 |   | 3,987 |
| Bill W. Colston       |   | 8,724 |   | 4,663 |
| Patrick S. Jones      |   | 116,396 |   | 3,987 |
| Carlos Paya           |   | 40,396 |   | 8,987 |

|     |                                                                          |
|-----|--------------------------------------------------------------------------|
| (1) | Amount includes RSUs with respect to which settlement has been deferred. |

----

|                                                                    |
|--------------------------------------------------------------------|
|                                                                    |  |  |  |  |  |  |  |  |
|                                                               |   | Number of  Securities to be  Issued Upon  Exercise of  Outstanding  Options,  Warrants and  Rights(a) |   | Weighted  Average  Exercise Price  of Outstanding  Options,  Warrants and  Rights(b) |   | Number of  Securities  Remaining  Available for  Future Issuance  Under Equity  Compensation  Plans (Excluding  Securities  Reflected in  Column (a)) |
| Equity compensation plans approved by security holders             |   |   |   |   |   |   |
| 2009 Equity Incentive Plan(1)                       |   | 27,904 |   | $ | 7.15 |  |   | — |
| 2011 Equity Incentive Plan                                         |   | 4,598,599 |   | $ | 8.05 |  |   | 5,312,076 |
| 2017 Employee Stock Purchase Plan                                  |   | — |   | — |  |   | 401,265 |
| Equity compensation plans not approved by security holders         |   |   |   |   |   |   |
| DVS Sciences, Inc. 2010 Equity Incentive Plan(2)    |   | 22,918 |   | $ | 0.94 |  |   | — |
| 2017 Inducement Award Plan(3)                  |   | 539,064 |   | $ | 6.30 |  |   | — |
| Total                                                              |   | 5,188,485 |   | $ | 7.78 |  |   |   |

|     |                                                                                                                                                                                                                                                                                                                      |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | The 2009 Equity Incentive Plan was replaced by the 2011 Equity Incentive Plan in February 2011. A total of 55,423 shares remaining available for grant under the 2009 Equity Incentive Plan were transferred to the 2011 Equity Incentive Plan and the 2009 Equity Incentive Plan was terminated for any new grants. |
|     |                                                                                                      |
|-----|------------------------------------------------------------------------------------------------------|
| (2) | Represents awards assumed in connection with our acquisition of DVS Sciences, Inc. in February 2014. |
|     |                                                                                         |
|-----|-----------------------------------------------------------------------------------------|
| (3) | The Fluidigm 2017 Inducement Award Plan was terminated in June 2019 for any new grants. |

----

|                                                                          |
|--------------------------------------------------------------------------|
|                                                                          |  |  |  |  |
| Name of Beneficial Owner                                                 |   | Shares Beneficially Owned |   | Percent of Shares Beneficially Owned |
| 5% Stockholders:                                                         |   |   |   |   |
| Indaba Capital Management, L.P.(1)                                       |   | 7,278,524 |   | 9.7% |
| PRIMECAP Management Company(2)                                           |   | 6,477,843 |   | 9.2% |
| Neuberger Berman Group LLC(3)                                            |   | 5,669,341 |   | 8.0% |
| BlackRock, Inc.(4)                                                       |   | 5,290,321 |   | 7.5% |
| Levin Easterly Partners LLC(5)                                           |   | 5,128,573 |   | 7.3% |
| The Vanguard Group(6)                                                    |   | 4,409,776 |   | 6.2% |
| Directors and NEOs:                                                      |   |   |   |   |
| Stephen Christopher Linthwaite(7)                                        |   | 613,383 |   | * |
| Nicolas M. Barthelemy(8)                                                 |   | 177,069 |   | * |
| Gerhard F. Burbach(9)                                                    |   | 134,598 |   | * |
| Laura M. Clague(10)                                                      |   | 17,033 |   | * |
| Samuel D. Colella(11)                                                    |   | 249,843 |   | * |
| Bill W. Colston                                                          |   | — |   | — |
| Patrick S. Jones(12)                                                     |   | 139,483 |   | * |
| Carlos V. Paya(13)                                                       |   | 79,989 |   | * |
| Vikram Jog(14)                                                           |   | 220,666 |   | * |
| Nicholas S. Khadder(15)                                                  |   | 116,464 |   | * |
| Bradley Kreger(16)                                                       |   | 78,936 |   | * |
| Colin McCracken(17)                                                      |   | 22,023 |   | * |
| All current directors and executive officers as a group (12 persons)(18) |   | 831,659 |   | 2.6% |

|     |                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Information is as of December 31, 2019, the latest date for which information is available to the Company. According to a Schedule 13G filed jointly by Indaba Capital Management, L.P., IC GP, LLC (“IC GP”), Indaba’s sole general partner, and Derek C. Schrier, the managing member of IC GP, shared voting and dispositive power is held with respect with respect to all of such shares. Reported shares include |

----

|     |                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Information is as of December 31, 2019, the latest date for which information is available to the Company. According to a Schedule 13G/A filed by PRIMECAP Management Company, which identified itself as an investment adviser, sole voting and dispositive power is held with respect to all of such shares. PRIMECAP’s address is 177 E. Colorado Blvd., 11th Floor, Pasadena, CA 91105. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3) | Information is as of December 31, 2019, the latest date for which information is available to the Company. According to a Schedule 13G/A filed jointly by Neuberger Berman Group LLC, which identified itself as a parent holding company, and Neuberger Berman Investment Advisers LLC, which identified itself as an investment adviser, shared dispositive power is held with respect to all of such shares and shared voting power is held with respect to 4,622,395 shares. Neuberger Berman’s address is 1290 Avenue of the Americas, New York, NY 10104. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | Information is as of December 31, 2019, the latest date for which information is available to the Company. According to a Schedule 13G filed by BlackRock, Inc., which identified itself as a parent holding company, sole dispositive power is held with respect to all of such shares and sole voting power is held with respect to 5,186,586 shares. BlackRock’s address is 55 East 52nd Street, New York, NY 10055. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5) | Information is as of December 31, 2019, the latest date for which information is available to the Company. According to a Schedule 13G/A filed jointly by Levin Easterly Partners LLC (which identified itself as an investment adviser), LE Partners Holdings LLC, LE Partners Holdings II LLC, LE Partners Holdings III LLC, LE Partners Holdings IV LLC, John “Jack” Murphy, Darrell Crate, and Avshalom Kalichstein, shared dispositive power is held with respect all of such shares and shared voting power is held with respect to 4,065,867 shares. Levin Easterly’s address is 595 Madison Avenue, 17th Floor, New York, NY 10022. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6) | Information is as of December 31, 2019, the latest date for which information is available to the Company. According to a Schedule 13G filed by The Vanguard Group, which identified itself as an investment adviser, sole voting power is held with respect to 147,604 shares, shared voting power is held with respect to 5,387 shares, sole dispositive power is held with respect to 4,264,839 shares, and shared dispositive power is held with respect to 144,937 shares. Vanguard’s address is 100 Vanguard Blvd., Malvern, PA 19355. |
|     |                                                                                                                                                                                                                                                  |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (7) | Consists of 196,593 shares held by Stephen Christopher Linthwaite, options to purchase 397,346 shares of common stock that are exercisable within 60 days of April 13, 2020, and 19,444 RSUs scheduled to vest within 60 days of April 13, 2020. |
|     |                                                                                                                                                                                                                                                                                          |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (8) | Consists of 136,436 shares held by the Barthelemy 2001 Trust, of which Mr. Barthelemy is a trustee, options to purchase 36,646 shares of common stock that are exercisable within 60 days of April 13, 2020, and 3,987 RSUs that are scheduled to vest within 60 days of April 13, 2020. |
|     |                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (9) | Consists of 8,000 shares held by Gerhard F. Burbach, options to purchase 92,396 shares of common stock that are exercisable within 60 days of April 13, 2020, and 30,215 RSUs that are vested or scheduled to vest within 60 days of April 13, 2020 and with respect to which Mr. Burbach has deferred settlement as described in “Compensation of Directors - RSUs in Lieu of Cash and RSU Deferral.” |
|      |                                                                                                                                                                                                                                                                                                                                                                     |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (10) | Consists of options to purchase 10,546 shares of common stock that are exercisable within 60 days of April 13, 2020, and 6,487 RSUs that are vested or scheduled to vest within 60 days of April 13, 2020 with respect to which Ms. Clague has deferred settlement as described in “Compensation of Directors - RSUs in Lieu of Cash and RSU Deferral.” |
|      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (11) | Consists of 140,901 shares held by Samuel D. Colella, 5,561 shares held by The Colella Family Partners, L.P., of which Mr. Colella is the general partner, 69,272 shares held by the Colella Family Exempt Marital Deduction Trust dated 9/21/1992 of which Mr. Colella is a trustee, 3,326 shares held by the Colella Family Non-Exempt Marital Deduction Trust dated 9/21/1992 of which Mr. Colella is a trustee, options to purchase 26,796 shares of common stock that are exercisable within 60 days of April 13, 2020, and 3,987 RSUs that are scheduled to vest within 60 days of April 13, 2020. |
|      |                                                                                                                                                                                                                                               |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (12) | Consists of 19,100 shares held by Patrick S. Jones, options to purchase 116,396 shares of common stock that are exercisable within 60 days of April 13, 2020, and 3,987 RSUs that are scheduled to vest within 60 days of April 13, 2020. |
|      |                                                                                                                                                                                                                                        |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (13) | Consists of 39,356 shares held by Carlos V. Paya, options to purchase 36,646 shares of common stock that are exercisable within 60 days of April 13, 2020, and 3,987 RSUs that are scheduled to vest within 60 days of April 13, 2020. |
|      |                                                                                                                                                                                                                                                                                                                                                  |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (14) | Consists of 52,762 shares held by Vikram Jog, 52,061 shares held by the Vikram and Pratima Jog Family Trust U/A dated June 23, 2009, of which Mr. Jog is a trustee, options to purchase 109,193 shares of common stock that are exercisable within 60 days of April 13, 2020, and 6,650 RSUs scheduled to vest within 60 days of April 13, 2020. |
|      |                                                                                                                                                                 |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (15) | Consists of 50,668 shares held by Nicholas Khadder and options to purchase 65,786 shares of common stock that are exercisable within 60 days of April 13, 2020. |
|      |                                                                                                                                                                                                                               |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (16) | Consists of 19,401 shares held by Bradley Kreger, options to purchase 54,174 shares of common stock that are exercisable within 60 days of April 13, 2020, and 5,361 RSUs scheduled to vest within 60 days of April 13, 2020. |
|      |                                                                                                                      |
|------|----------------------------------------------------------------------------------------------------------------------|
| (17) | Consists of 5,507 shares held by Colin McCracken and 16,516 RSUs scheduled to vest within 60 days of April 13, 2020. |
|      |                                                                                                                                                                                                                                                                                                                                                                                                                                |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (18) | Consists of 798,944 shares beneficially owned by current directors and NEOs, options held by current directors and NEOs to purchase 945,925 shares of common stock that are exercisable within 60 days of April 13, 2020, 71,893 RSUs held by current directors and executive officers that are scheduled to vest within 60 days of April 13, 2020, and 32,715 vested RSUs with respect to which settlement has been deferred. |

----

----

|                       |
|-----------------------|
|                       |  |  |  |  |  |
|                  |   | 2019 |   | 2018 |
| Audit fees(1)         |   | $1,763,821 |   | $1,643,990 |  |
| Audit-related fees(2) |   | 331,229 |   | — |  |
| Tax fees(3)           |   | 140,000 |   | — |  |
| All other fees(4)     |   | 4,500 |   | 3,600 |  |
| Total fees            |   | $2,239,550 |   | $1,647,590 |  |

|     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1) | Audit fees for 2019 consist of fees billed or to be billed by PricewaterhouseCoopers LLP for professional services rendered for the integrated audit of our annual consolidated financial statements and management’s report on internal controls included in our Annual Report on Form 10-K; for the review of the consolidated financial statements included in our quarterly reports on Form 10-Q; and for other services, including statutory audits and services rendered in connection with SEC filings. We note that for year 2018, $132,355 of the fees were reclassified from audit-related fees to audit fees to conform to the current year’s presentation. |
|     |                                                                                                                                                                                                                                                                                                                            |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Audit-related fees consist of fees for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include consultations concerning financial accounting and reporting standards. |
|     |                                                                                                                                                          |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3) | Tax fees consist of fees billed by PricewaterhouseCoopers LLP for professional services rendered for tax compliance, consultation and planning services. |
|     |                                                                                                                                                                                                                                                                                                 |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | All other fees consist of fees billed by PricewaterhouseCoopers LLP for professional services other than the services reported above. These fees primarily consist of fees attributable to permissible consulting services as well as fees to license specialized accounting research software. |

----

|                 |
|-----------------|
|                 |  |  |  |  |
| Exhibit  Number |   | Description |   | Incorporated by Reference From Form |
| 31.3            |   | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer. |   | Filed herewith |
| 31.4            |   | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer. |   | Filed herewith |
| 104             |   | The cover page from this Amendment No. 1 on Form 10-K/A, formatted in Inline XBRL. |   | Filed herewith |

----

|                       |
|-----------------------|
|                       |  |  |
|                  | FLUIDIGM CORPORATION |
| Dated: April 28, 2020 | By: | /s/ Stephen Christopher Linthwaite |
|                  | Stephen Christopher Linthwaite |
|                  | President and Chief Executive Officer |

|                                    |
|------------------------------------|
|                                    |  |  |  |  |
| Signature                          |   | Title |   | Date |
|                               |   |   |
| /s/ Stephen Christopher Linthwaite |   | President and Chief Executive Officer (Principal Executive Officer); Director |   | April 28, 2020 |
| Stephen Christopher Linthwaite     |   |   |   |   |
| /s/ Vikram Jog                     |   | Chief Financial Officer (Principal Financial and Accounting Officer) |   | April 28, 2020 |
| Vikram Jog                         |   |   |
| *                                  |   | Chairman of the Board of Directors |   | April 28, 2020 |
| Samuel D. Colella                  |   |   |
| *                                  |   | Director |   | April 28, 2020 |
| Nicolas M. Barthelemy              |   |   |
| *                                  |   | Director |   | April 28, 2020 |
| Gerhard F. Burbach                 |   |   |
| *                                  |   | Director |   | April 28, 2020 |
| Laura M. Clague                    |   |   |
| *                                  |   | Director |   | April 28, 2020 |
| Bill W. Colston                    |   |   |   |   |
| *                                  |   | Director |   | April 28, 2020 |
| Patrick S. Jones                   |   |   |
| *                                  |   | Director |   | April 28, 2020 |
| Carlos V. Paya                     |   |   |   |   |

|        |
|--------|
|        |  |
| *By:   | /s/ Vikram Jog |
|   | Vikram Jog, as attorney-in-fact |

----

|                 |
|-----------------|
|                 |  |  |  |  |
| Exhibit  Number |   | Description |   | Incorporated by Reference From Form |
| 31.3            |   | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer. |   | Filed herewith |
| 31.4            |   | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer. |   | Filed herewith |
| 104             |   | The cover page from this Amendment No. 1 on Form 10-K/A, formatted in Inline XBRL. |   | Filed herewith |